Alternative versus classical macrophage activation during experimental African trypanosomosis

The type I/type II cytokine balance may influence the development of different subsets of suppressive macrophages, i.e., classically activated macrophages (caMφ, type I) versus alternatively activated macrophages (aaMφ, type II). Recently, we showed that although mice infected with phospholipase C‐d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of leukocyte biology 2001-03, Vol.69 (3), p.387-396
Hauptverfasser: Namangala, Boniface, De Baetselier, Patrick, Noël, Wim, Brys, Lea, Beschin, Alain
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 396
container_issue 3
container_start_page 387
container_title Journal of leukocyte biology
container_volume 69
creator Namangala, Boniface
De Baetselier, Patrick
Noël, Wim
Brys, Lea
Beschin, Alain
description The type I/type II cytokine balance may influence the development of different subsets of suppressive macrophages, i.e., classically activated macrophages (caMφ, type I) versus alternatively activated macrophages (aaMφ, type II). Recently, we showed that although mice infected with phospholipase C‐deficient (PLC−/−) Trypanosoma brucei brucei exhibit a clear shift from type I to the type II cytokine production, wild type (WT)‐infected mice remain locked in a type I cytokine response. In the present study, phenotype and accessory cell function of macrophages elicited during WT and PLC−/− T. b. brucei infection were compared. Results indicate that caMφ develop in a type I cytokine environment in the early phase of WT and PLC−/− trypanosome infection, correlating with inhibition of T cell activation triggered by a mitogen, a superantigen, or an antigen. In the late stage of infection, only PLC−/−‐infected mice resisting the infection develop type II cytokine‐associated aaMφ correlating with impaired antigen‐ but not mitogen‐ or superantigen‐induced T cell activation.
doi_str_mv 10.1189/jlb.69.3.387
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76989253</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17843655</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4567-fa265dd5aa003e3fbd3d6db83fd508da04d3586ff013f4a200a9cba22d164dc73</originalsourceid><addsrcrecordid>eNqFkD1v2zAQhokgRey42TIHWtIpUkhRpKTRDfoJA1mSsSBOImnToD5CSlb978NARrOl0y3Pve_dg9A1wQkhRXm_t1XCy4QmtMjP0JKUtIgpz-k5WuI8IzHLMF6gS-_3GGOacnyBFoSknOQFW6I_azso18JgDio6KOdHH9UWvDc12KiB2nX9DrYqgjogAevaSI7OtNtI_e2VM41qh0CutQsbbTS4Yw9t57um88Z_Rp80WK-uTnOFnr9_e3r4GW8ef_x6WG_iOmM8jzWknEnJAMKFiupKUsllVVAtGS4k4ExSVnCtMaE6gxRjKOsK0lQSnsk6pyv0Zc7tXfcyKj-IxvhaWQut6kYvcl4WZcrof8EgJaOcsQDezWAQ4L1TWvThV3BHQbB48y6Cd8FLQUXwHvCbU-5YNUq-wyfRASAzMBmrjh-Gid-br3gOvZ13dma7m4xTwjdgbahIxTRN_8pfAbKpnb0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17843655</pqid></control><display><type>article</type><title>Alternative versus classical macrophage activation during experimental African trypanosomosis</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Namangala, Boniface ; De Baetselier, Patrick ; Noël, Wim ; Brys, Lea ; Beschin, Alain</creator><creatorcontrib>Namangala, Boniface ; De Baetselier, Patrick ; Noël, Wim ; Brys, Lea ; Beschin, Alain</creatorcontrib><description>The type I/type II cytokine balance may influence the development of different subsets of suppressive macrophages, i.e., classically activated macrophages (caMφ, type I) versus alternatively activated macrophages (aaMφ, type II). Recently, we showed that although mice infected with phospholipase C‐deficient (PLC−/−) Trypanosoma brucei brucei exhibit a clear shift from type I to the type II cytokine production, wild type (WT)‐infected mice remain locked in a type I cytokine response. In the present study, phenotype and accessory cell function of macrophages elicited during WT and PLC−/− T. b. brucei infection were compared. Results indicate that caMφ develop in a type I cytokine environment in the early phase of WT and PLC−/− trypanosome infection, correlating with inhibition of T cell activation triggered by a mitogen, a superantigen, or an antigen. In the late stage of infection, only PLC−/−‐infected mice resisting the infection develop type II cytokine‐associated aaMφ correlating with impaired antigen‐ but not mitogen‐ or superantigen‐induced T cell activation.</description><identifier>ISSN: 0741-5400</identifier><identifier>EISSN: 1938-3673</identifier><identifier>DOI: 10.1189/jlb.69.3.387</identifier><identifier>PMID: 11261785</identifier><language>eng</language><publisher>United States: Society for Leukocyte Biology</publisher><subject>Animals ; antigen presentation ; Antigen Presentation - immunology ; Arginase - blood ; Ascitic Fluid - metabolism ; Ascitic Fluid - pathology ; Concanavalin A - pharmacology ; Enterotoxins - immunology ; Enterotoxins - pharmacology ; Epitopes, T-Lymphocyte - immunology ; Female ; immunosuppression ; Interferon-gamma - biosynthesis ; Interleukins - biosynthesis ; Lymphocyte Activation - drug effects ; Lymphocyte Activation - immunology ; Macrophage Activation - drug effects ; Macrophage Activation - immunology ; Macrophages, Peritoneal - drug effects ; Macrophages, Peritoneal - immunology ; Macrophages, Peritoneal - metabolism ; Mice ; Mice, Inbred BALB C ; Mitogens - pharmacology ; Muramidase - immunology ; Muramidase - pharmacology ; Nitric Oxide - blood ; Phenotype ; phospholipase C ; Superantigens - immunology ; Superantigens - pharmacology ; T-Lymphocytes - drug effects ; T-Lymphocytes - immunology ; Trypanosoma brucei brucei ; Trypanosoma brucei brucei - enzymology ; Trypanosoma brucei brucei - genetics ; trypanosome infection ; Trypanosomiasis, African - blood ; Trypanosomiasis, African - immunology ; Type C Phospholipases - deficiency ; Type C Phospholipases - genetics</subject><ispartof>Journal of leukocyte biology, 2001-03, Vol.69 (3), p.387-396</ispartof><rights>2001 Society for Leukocyte Biology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4567-fa265dd5aa003e3fbd3d6db83fd508da04d3586ff013f4a200a9cba22d164dc73</citedby><cites>FETCH-LOGICAL-c4567-fa265dd5aa003e3fbd3d6db83fd508da04d3586ff013f4a200a9cba22d164dc73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1189%2Fjlb.69.3.387$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1189%2Fjlb.69.3.387$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11261785$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Namangala, Boniface</creatorcontrib><creatorcontrib>De Baetselier, Patrick</creatorcontrib><creatorcontrib>Noël, Wim</creatorcontrib><creatorcontrib>Brys, Lea</creatorcontrib><creatorcontrib>Beschin, Alain</creatorcontrib><title>Alternative versus classical macrophage activation during experimental African trypanosomosis</title><title>Journal of leukocyte biology</title><addtitle>J Leukoc Biol</addtitle><description>The type I/type II cytokine balance may influence the development of different subsets of suppressive macrophages, i.e., classically activated macrophages (caMφ, type I) versus alternatively activated macrophages (aaMφ, type II). Recently, we showed that although mice infected with phospholipase C‐deficient (PLC−/−) Trypanosoma brucei brucei exhibit a clear shift from type I to the type II cytokine production, wild type (WT)‐infected mice remain locked in a type I cytokine response. In the present study, phenotype and accessory cell function of macrophages elicited during WT and PLC−/− T. b. brucei infection were compared. Results indicate that caMφ develop in a type I cytokine environment in the early phase of WT and PLC−/− trypanosome infection, correlating with inhibition of T cell activation triggered by a mitogen, a superantigen, or an antigen. In the late stage of infection, only PLC−/−‐infected mice resisting the infection develop type II cytokine‐associated aaMφ correlating with impaired antigen‐ but not mitogen‐ or superantigen‐induced T cell activation.</description><subject>Animals</subject><subject>antigen presentation</subject><subject>Antigen Presentation - immunology</subject><subject>Arginase - blood</subject><subject>Ascitic Fluid - metabolism</subject><subject>Ascitic Fluid - pathology</subject><subject>Concanavalin A - pharmacology</subject><subject>Enterotoxins - immunology</subject><subject>Enterotoxins - pharmacology</subject><subject>Epitopes, T-Lymphocyte - immunology</subject><subject>Female</subject><subject>immunosuppression</subject><subject>Interferon-gamma - biosynthesis</subject><subject>Interleukins - biosynthesis</subject><subject>Lymphocyte Activation - drug effects</subject><subject>Lymphocyte Activation - immunology</subject><subject>Macrophage Activation - drug effects</subject><subject>Macrophage Activation - immunology</subject><subject>Macrophages, Peritoneal - drug effects</subject><subject>Macrophages, Peritoneal - immunology</subject><subject>Macrophages, Peritoneal - metabolism</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mitogens - pharmacology</subject><subject>Muramidase - immunology</subject><subject>Muramidase - pharmacology</subject><subject>Nitric Oxide - blood</subject><subject>Phenotype</subject><subject>phospholipase C</subject><subject>Superantigens - immunology</subject><subject>Superantigens - pharmacology</subject><subject>T-Lymphocytes - drug effects</subject><subject>T-Lymphocytes - immunology</subject><subject>Trypanosoma brucei brucei</subject><subject>Trypanosoma brucei brucei - enzymology</subject><subject>Trypanosoma brucei brucei - genetics</subject><subject>trypanosome infection</subject><subject>Trypanosomiasis, African - blood</subject><subject>Trypanosomiasis, African - immunology</subject><subject>Type C Phospholipases - deficiency</subject><subject>Type C Phospholipases - genetics</subject><issn>0741-5400</issn><issn>1938-3673</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkD1v2zAQhokgRey42TIHWtIpUkhRpKTRDfoJA1mSsSBOImnToD5CSlb978NARrOl0y3Pve_dg9A1wQkhRXm_t1XCy4QmtMjP0JKUtIgpz-k5WuI8IzHLMF6gS-_3GGOacnyBFoSknOQFW6I_azso18JgDio6KOdHH9UWvDc12KiB2nX9DrYqgjogAevaSI7OtNtI_e2VM41qh0CutQsbbTS4Yw9t57um88Z_Rp80WK-uTnOFnr9_e3r4GW8ef_x6WG_iOmM8jzWknEnJAMKFiupKUsllVVAtGS4k4ExSVnCtMaE6gxRjKOsK0lQSnsk6pyv0Zc7tXfcyKj-IxvhaWQut6kYvcl4WZcrof8EgJaOcsQDezWAQ4L1TWvThV3BHQbB48y6Cd8FLQUXwHvCbU-5YNUq-wyfRASAzMBmrjh-Gid-br3gOvZ13dma7m4xTwjdgbahIxTRN_8pfAbKpnb0</recordid><startdate>200103</startdate><enddate>200103</enddate><creator>Namangala, Boniface</creator><creator>De Baetselier, Patrick</creator><creator>Noël, Wim</creator><creator>Brys, Lea</creator><creator>Beschin, Alain</creator><general>Society for Leukocyte Biology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>200103</creationdate><title>Alternative versus classical macrophage activation during experimental African trypanosomosis</title><author>Namangala, Boniface ; De Baetselier, Patrick ; Noël, Wim ; Brys, Lea ; Beschin, Alain</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4567-fa265dd5aa003e3fbd3d6db83fd508da04d3586ff013f4a200a9cba22d164dc73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Animals</topic><topic>antigen presentation</topic><topic>Antigen Presentation - immunology</topic><topic>Arginase - blood</topic><topic>Ascitic Fluid - metabolism</topic><topic>Ascitic Fluid - pathology</topic><topic>Concanavalin A - pharmacology</topic><topic>Enterotoxins - immunology</topic><topic>Enterotoxins - pharmacology</topic><topic>Epitopes, T-Lymphocyte - immunology</topic><topic>Female</topic><topic>immunosuppression</topic><topic>Interferon-gamma - biosynthesis</topic><topic>Interleukins - biosynthesis</topic><topic>Lymphocyte Activation - drug effects</topic><topic>Lymphocyte Activation - immunology</topic><topic>Macrophage Activation - drug effects</topic><topic>Macrophage Activation - immunology</topic><topic>Macrophages, Peritoneal - drug effects</topic><topic>Macrophages, Peritoneal - immunology</topic><topic>Macrophages, Peritoneal - metabolism</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mitogens - pharmacology</topic><topic>Muramidase - immunology</topic><topic>Muramidase - pharmacology</topic><topic>Nitric Oxide - blood</topic><topic>Phenotype</topic><topic>phospholipase C</topic><topic>Superantigens - immunology</topic><topic>Superantigens - pharmacology</topic><topic>T-Lymphocytes - drug effects</topic><topic>T-Lymphocytes - immunology</topic><topic>Trypanosoma brucei brucei</topic><topic>Trypanosoma brucei brucei - enzymology</topic><topic>Trypanosoma brucei brucei - genetics</topic><topic>trypanosome infection</topic><topic>Trypanosomiasis, African - blood</topic><topic>Trypanosomiasis, African - immunology</topic><topic>Type C Phospholipases - deficiency</topic><topic>Type C Phospholipases - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Namangala, Boniface</creatorcontrib><creatorcontrib>De Baetselier, Patrick</creatorcontrib><creatorcontrib>Noël, Wim</creatorcontrib><creatorcontrib>Brys, Lea</creatorcontrib><creatorcontrib>Beschin, Alain</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of leukocyte biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Namangala, Boniface</au><au>De Baetselier, Patrick</au><au>Noël, Wim</au><au>Brys, Lea</au><au>Beschin, Alain</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alternative versus classical macrophage activation during experimental African trypanosomosis</atitle><jtitle>Journal of leukocyte biology</jtitle><addtitle>J Leukoc Biol</addtitle><date>2001-03</date><risdate>2001</risdate><volume>69</volume><issue>3</issue><spage>387</spage><epage>396</epage><pages>387-396</pages><issn>0741-5400</issn><eissn>1938-3673</eissn><abstract>The type I/type II cytokine balance may influence the development of different subsets of suppressive macrophages, i.e., classically activated macrophages (caMφ, type I) versus alternatively activated macrophages (aaMφ, type II). Recently, we showed that although mice infected with phospholipase C‐deficient (PLC−/−) Trypanosoma brucei brucei exhibit a clear shift from type I to the type II cytokine production, wild type (WT)‐infected mice remain locked in a type I cytokine response. In the present study, phenotype and accessory cell function of macrophages elicited during WT and PLC−/− T. b. brucei infection were compared. Results indicate that caMφ develop in a type I cytokine environment in the early phase of WT and PLC−/− trypanosome infection, correlating with inhibition of T cell activation triggered by a mitogen, a superantigen, or an antigen. In the late stage of infection, only PLC−/−‐infected mice resisting the infection develop type II cytokine‐associated aaMφ correlating with impaired antigen‐ but not mitogen‐ or superantigen‐induced T cell activation.</abstract><cop>United States</cop><pub>Society for Leukocyte Biology</pub><pmid>11261785</pmid><doi>10.1189/jlb.69.3.387</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0741-5400
ispartof Journal of leukocyte biology, 2001-03, Vol.69 (3), p.387-396
issn 0741-5400
1938-3673
language eng
recordid cdi_proquest_miscellaneous_76989253
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals
subjects Animals
antigen presentation
Antigen Presentation - immunology
Arginase - blood
Ascitic Fluid - metabolism
Ascitic Fluid - pathology
Concanavalin A - pharmacology
Enterotoxins - immunology
Enterotoxins - pharmacology
Epitopes, T-Lymphocyte - immunology
Female
immunosuppression
Interferon-gamma - biosynthesis
Interleukins - biosynthesis
Lymphocyte Activation - drug effects
Lymphocyte Activation - immunology
Macrophage Activation - drug effects
Macrophage Activation - immunology
Macrophages, Peritoneal - drug effects
Macrophages, Peritoneal - immunology
Macrophages, Peritoneal - metabolism
Mice
Mice, Inbred BALB C
Mitogens - pharmacology
Muramidase - immunology
Muramidase - pharmacology
Nitric Oxide - blood
Phenotype
phospholipase C
Superantigens - immunology
Superantigens - pharmacology
T-Lymphocytes - drug effects
T-Lymphocytes - immunology
Trypanosoma brucei brucei
Trypanosoma brucei brucei - enzymology
Trypanosoma brucei brucei - genetics
trypanosome infection
Trypanosomiasis, African - blood
Trypanosomiasis, African - immunology
Type C Phospholipases - deficiency
Type C Phospholipases - genetics
title Alternative versus classical macrophage activation during experimental African trypanosomosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T00%3A08%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alternative%20versus%20classical%20macrophage%20activation%20during%20experimental%20African%20trypanosomosis&rft.jtitle=Journal%20of%20leukocyte%20biology&rft.au=Namangala,%20Boniface&rft.date=2001-03&rft.volume=69&rft.issue=3&rft.spage=387&rft.epage=396&rft.pages=387-396&rft.issn=0741-5400&rft.eissn=1938-3673&rft_id=info:doi/10.1189/jlb.69.3.387&rft_dat=%3Cproquest_cross%3E17843655%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17843655&rft_id=info:pmid/11261785&rfr_iscdi=true